News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
December 1, 2022
2022

AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

Event
November 14, 2022
2022

PEGS Europe 2022

News
November 10, 2022
2022

AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022

News
November 8, 2022
2022

AbCellera Reports Q3 2022 Business Results

Event
November 7, 2022
2022

Antibody Engineering & Therapeutics USA 2022

News
November 4, 2022
2022

AbCellera to Present at Upcoming Investor Conferences in November

News
November 2, 2022
2022

AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

News
October 11, 2022
2022

AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022

News
October 5, 2022
2022

AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022

Event
October 5, 2022
2022

SITC Annual Meeting 2022